The Pharma Letter

Study adds to evidence for a public health value of a Beyfortus immunization program

A universal respiratory syncytial virus (RSV) immunization program using Sanofi’s Beyfortus (nirsevimab) was associated with ...

Press Release: Beyfortus study published in The Lancet Infectious Diseases shows benefit for infants beyond first RSV season

Beyfortus study published in The Lancet Infectious Diseases shows benefit for infants beyond first RSV season First study showing that infants immunized against RSV in their first season had fewer RSV ...
EurekAlert!

Universal infant hepatitis B immunization recommended

All countries should offer universal infant immunization for hepatitis B, write Dr. Christopher Mackie from McMaster University and coauthors in a public health ...
Business Insider

Takeda Selects Shot@Life for Annual Global Corporate Social Responsibility (CSR) Program, Supporting Immunization and Universal Health Coverage in Sub-Saharan Africa

WASHINGTON, July 30, 2019 /PRNewswire-PRWeb/ -- The United Nations Foundation's Shot@Life campaign, which helps expand access to life-saving childhood vaccines globally, is proud to share an expanded ...
News Medical

India's Mission Indradhanush improves vaccination outcomes for children

Researchers at CDDEP recently published 'Improving vaccination coverage and timeliness through periodic intensification of routine immunization: evidence from Mission Indradhanush' where they ...

Sanofi: Beyfortus study published in The Lancet Infectious Diseases shows benefit for infants beyond first RSV season

Beyfortus study published in The Lancet Infectious Diseases shows benefit for infants beyond first RSV season First study showing that infants immunized against RSV in their first season had fewer ...